BR0309174A - Preparação terapêutica na forma de pó seco - Google Patents

Preparação terapêutica na forma de pó seco

Info

Publication number
BR0309174A
BR0309174A BR0309174-0A BR0309174A BR0309174A BR 0309174 A BR0309174 A BR 0309174A BR 0309174 A BR0309174 A BR 0309174A BR 0309174 A BR0309174 A BR 0309174A
Authority
BR
Brazil
Prior art keywords
nozzle
dose
powder
dry powder
air
Prior art date
Application number
BR0309174-0A
Other languages
English (en)
Inventor
Myrman Mattias
Nilsson Per-Gunnar
Original Assignee
Microdrug Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microdrug Ag filed Critical Microdrug Ag
Publication of BR0309174A publication Critical patent/BR0309174A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/001Particle size control
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • A61M15/0046Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier
    • A61M15/0048Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier the dosages being arranged in a plane, e.g. on diskettes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • A61M15/0046Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier
    • A61M15/005Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier the dosages being arranged on a cylindrical surface
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/02Inhalators with activated or ionised fluids, e.g. electrohydrodynamic [EHD] or electrostatic devices; Ozone-inhalators with radioactive tagged particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/06Solids
    • A61M2202/064Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Pulmonology (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"PREPARAçãO TERAPêUTICA NA FORMA DE Pó SECO". A presente invenção divulga uma preparação terapêutica na forma de pó seco e um método de administração de tal preparação, para efetivamente desagregar e dispersar no ar uma dose de pó de medicamento em uma administração de uma dose a um usuário. A presente preparação de pó seco e respectivo método não requerem outras fontes de energia, além da energia de um esforço de inalação realizado por um usuário para produzir um grau bastante alto de desagregação e eficiente dispersão no ar da dose de medicamento de pó seco. Utilizando um esforço de sucção de ar através de um bocal, as partículas da dose de pó terapêutico tornadas disponíveis para o bocal são gradualmente desagregadas e dispersas numa corrente de ar que entra no bocal. A gradual desagregação e dispersão e produzida por um efeito de arraste, devido a um movimento relativo introduzido entre o bocal e a dose de pó. O bocal é geralmente posicionado externamente à área de pó e não entra em contato com o pó até que a corrente de ar dentro do bocal, criada pela sucção, tenha passado uma velocidade de fluxo limite. Coincidentemente com a aplicação da sucção, o movimento relativo irá começar de modo que o bocal cruze a dose de pó gradualmente. Esforços de cisalhamento e inércia da corrente de ar aplicada são tão poderosos que partículas nos agregados de partículas da dose de pó adjacente à admissão do bocal em movimento são liberadas e desagregadas em alto grau, assim como dispersas e subseq³entemente arrastadas na corrente de ar criada, que se dirigia através do bocal para o usuário da inalação.
BR0309174-0A 2002-04-12 2003-04-04 Preparação terapêutica na forma de pó seco BR0309174A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0201125A SE524990C2 (sv) 2002-04-12 2002-04-12 Preparation av terapeutiskt torrt pulver samt förfarande för uppdelning och spridning i luft av medicinskt pulver
PCT/SE2003/000540 WO2003086516A1 (en) 2002-04-12 2003-04-04 Therapeutic dry powder preparation

Publications (1)

Publication Number Publication Date
BR0309174A true BR0309174A (pt) 2005-02-09

Family

ID=20287575

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0309174-0A BR0309174A (pt) 2002-04-12 2003-04-04 Preparação terapêutica na forma de pó seco

Country Status (12)

Country Link
US (1) US6881398B2 (pt)
EP (1) EP1496967A1 (pt)
JP (1) JP2005522494A (pt)
KR (1) KR20040097351A (pt)
AU (1) AU2003222538B2 (pt)
BR (1) BR0309174A (pt)
CA (1) CA2482263A1 (pt)
MX (1) MXPA04010003A (pt)
RU (1) RU2333014C2 (pt)
SE (1) SE524990C2 (pt)
WO (1) WO2003086516A1 (pt)
ZA (1) ZA200408941B (pt)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030235538A1 (en) * 2002-04-09 2003-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for the administration of an anticholinergic by inhalation
SE524957C2 (sv) * 2002-04-12 2004-11-02 Microdrug Ag Förfarande för uppdelning och fördelning i luft av torrt pulvermedikament
SE0303270L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Metod för administration av tiotropium
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
SE0303569L (sv) * 2003-12-03 2005-06-04 Microdrug Ag DPI för avlämning av fuktkänsliga medikament
SE0303571D0 (sv) * 2003-12-03 2003-12-22 Microdrug Ag Medical product for moisture-sensitive medicaments
WO2005053647A1 (en) * 2003-12-03 2005-06-16 Microdrug Ag Medical product containing tiotropium
SE0303269L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Medicinsk produkt
RU2379062C2 (ru) * 2004-02-24 2010-01-20 Майкродоуз Терапьютикс, Инк. Способ и устройство для доставки медикамента на основе синтезирующей струи
SE528121C2 (sv) * 2004-03-29 2006-09-05 Mederio Ag Preparering av torrpulver för på förhand uppmätt DPI
SE530006C2 (sv) * 2004-06-18 2008-02-05 Mederio Ag Inhalator som använder balja
SE0402345L (sv) * 2004-09-24 2006-03-25 Mederio Ag Uppmätt läkemedelsdos
SE0402976L (sv) * 2004-12-03 2006-06-04 Mederio Ag Medicinsk produkt
TWI274641B (en) * 2005-08-30 2007-03-01 Rexon Ind Corp Ltd Cutting machine
US20070101991A1 (en) * 2005-11-08 2007-05-10 Mederio Ag Optimizing release of dry medicament powder
GB0616299D0 (en) * 2006-08-16 2006-09-27 Cambridge Consultants Drug Capsules for dry power inhalers
AU2007309412B2 (en) 2006-10-25 2011-10-20 Novartis Ag Powder dispersion apparatus, method of making and using the apparatus, and components that can be used on the apparatus and other devices
US8196576B2 (en) * 2007-02-28 2012-06-12 Microdose Therapeutx, Inc. Inhaler
BRPI0818874A2 (pt) * 2007-10-24 2015-05-05 Mannkind Corp Liberação de agentes ativos
EP2534958A1 (en) 2007-12-14 2012-12-19 AeroDesigns, Inc Delivering aerosolizable food products
RU2457855C2 (ru) * 2008-08-05 2012-08-10 Виктор Владимирович Чалов Противовирусная и антимикробная композиция
US8985101B2 (en) 2009-05-21 2015-03-24 Microdose Therapeutx, Inc. Method and device for clamping a blister within a dry powder inhaler
MX2011012265A (es) * 2009-05-21 2012-04-11 Microdose Therapeutx Inc Sistema de casete rotatorio para inhalador de polvo seco.
US9180263B2 (en) * 2009-07-01 2015-11-10 Microdose Therapeutx, Inc. Laboratory animal pulmonary dosing device
US20110000481A1 (en) * 2009-07-01 2011-01-06 Anand Gumaste Nebulizer for infants and respiratory compromised patients
EP3431128A1 (en) 2010-01-05 2019-01-23 MicroDose Therapeutx, Inc. Inhalation device and method
PL2672847T3 (pl) 2011-02-11 2015-10-30 Batmark Ltd Część składowa inhalatora
US9757395B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
US9757529B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
WO2014155192A2 (en) * 2013-03-26 2014-10-02 Optinose As Nasal administration
US11554229B2 (en) 2013-03-26 2023-01-17 OptiNose Inc. Nasal administration
EP3607941A1 (en) 2013-04-30 2020-02-12 Otitopic Inc. Dry powder formulations and methods of use
ES2922206T3 (es) 2014-02-20 2022-09-09 Otitopic Inc Formulaciones de polvo seco para la inhalación
US10610651B2 (en) * 2014-06-09 2020-04-07 Aerami Therapeutics, Inc. Self-puncturing liquid drug cartridges and associated dispenser
GB2535427A (en) 2014-11-07 2016-08-24 Nicoventures Holdings Ltd Solution
GB2542838B (en) * 2015-10-01 2022-01-12 Nicoventures Trading Ltd Aerosol provision system
WO2018071435A1 (en) 2016-10-11 2018-04-19 Microdose Therapeutx, Inc. Inhaler and methods of use thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2087911T3 (es) 1989-04-28 1996-08-01 Riker Laboratories Inc Dispositivo de inhalacion de polvo seco.
GB9024760D0 (en) 1990-11-14 1991-01-02 Riker Laboratories Inc Inhalation device and medicament carrier
US5469843A (en) 1991-11-12 1995-11-28 Minnesota Mining And Manufacturing Company Inhalation device
US5441060A (en) * 1993-02-08 1995-08-15 Duke University Dry powder delivery system
US5388573A (en) * 1993-12-02 1995-02-14 Tenax Corporation Dry powder inhalator medicament carrier
US5503869A (en) * 1994-10-21 1996-04-02 Glaxo Wellcome Inc. Process for forming medicament carrier for dry powder inhalator
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US5714007A (en) 1995-06-06 1998-02-03 David Sarnoff Research Center, Inc. Apparatus for electrostatically depositing a medicament powder upon predefined regions of a substrate
SE504458C2 (sv) 1995-06-21 1997-02-17 Lars Gunnar Nilsson Inhalator för elektrisk dosering av substanser
US5857456A (en) 1996-06-10 1999-01-12 Sarnoff Corporation Inhaler apparatus with an electronic means for enhanced release of dry powders
SE517806C2 (sv) * 1999-11-11 2002-07-16 Microdrug Ag Doseringsanordning för inhalator
SE516555C2 (sv) 2000-08-04 2002-01-29 Microdrug Ag Elektropulver
SE516554C2 (sv) 2000-08-31 2002-01-29 Microdrug Ag Uppmätt elektrodos
SE524957C2 (sv) * 2002-04-12 2004-11-02 Microdrug Ag Förfarande för uppdelning och fördelning i luft av torrt pulvermedikament

Also Published As

Publication number Publication date
US6881398B2 (en) 2005-04-19
ZA200408941B (en) 2007-12-27
RU2004132859A (ru) 2005-08-27
MXPA04010003A (es) 2005-07-01
SE0201125L (sv) 2003-10-13
US20030192540A1 (en) 2003-10-16
JP2005522494A (ja) 2005-07-28
WO2003086516A1 (en) 2003-10-23
RU2333014C2 (ru) 2008-09-10
AU2003222538B2 (en) 2007-05-03
SE0201125D0 (sv) 2002-04-12
AU2003222538A1 (en) 2003-10-27
SE524990C2 (sv) 2004-11-09
CA2482263A1 (en) 2003-10-23
EP1496967A1 (en) 2005-01-19
KR20040097351A (ko) 2004-11-17

Similar Documents

Publication Publication Date Title
BR0309174A (pt) Preparação terapêutica na forma de pó seco
BR0309175A (pt) Desagregação e dispersão de pó de medicamento seco no ar
MX9800826A (es) Dispositivo para inhaladores.
AU2009212849B2 (en) Unit dose cartridge and dry powder inhaler
JP5016486B2 (ja) 凝集化の少ない粉体吸入器
DE60115689D1 (de) Trockenpulverinhalator
AP1861A (en) Dry powder inhalation system for transpulmonary administration
BR0316603A (pt) Dispositivo de inalação para administração transpulmonar
JP6219542B2 (ja) 高用量薬剤供給用の粉末区画室
DE60116319D1 (de) Inhalatoren
TR199902899T2 (xx) Toz halinde kullan�lan ila�lar� solukla i�eri �ekmeye yarayan alet.
DE69121724D1 (de) Pulverinhalator
RU2010126838A (ru) Устройство раздачи и способ захвата порошкообразного средства в потоке воздуха 537
SE9700421D0 (sv) Single dose inhaler I
ME00297B (me) Inhalator praha
ES2150412T3 (es) Dispositivo para la pulverizacion mas eficaz de un medicamento en polvo para inhalacion.
Salati et al. Exhaled jet and viral-laden aerosol transport from nasal sneezing
BR0309173A (pt) Dispositivo constituinte de uma lâmina pneumática para pó
Coates et al. Simulation of the performance of a dry powder inhaler using computational fluid dynamics
GEP20074268B (en) Dry powder inhalation system for transpulmonary administration

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: MEDERIO AG (CH)

Free format text: TRANSFERIDO DE: MICRODRUG AG

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE AS 7A, 8A E 9A ANUIDADES.